Vaccine Effectiveness and Safety for the 2026-2027 Respiratory Season - COVID-19, RSV, Influenza
JAMA Special Communications - Three systematic reviews identify & summarise recent reporting on the effectiveness and safety of vaccines and influenza/RSV/Covid-19 epidemiology in the US.
WHO prequalifies multi-dose RSV vaccine vial, paving the way to protecting more infants globally
The WHO has prequalified the multi-dose vial presentation of the maternal respiratory syncytial virus (RSV) vaccine, RSVpreF (ABRYSVO®).
News
Reports
Partner Organisations
EHMA: Prepact - A Receptivity Assessment for HMPV and RSV Diagnosis in Older Adults
EMA White Paper assessing receptivity to improving testing and surveillance for RSV & HMPV across Europe, with a specific focus on older adults.
Article
News
In the media
Policy & Recommendations
#IDCBreathAndBeyond calls for respiratory virus prevention to be fully integrated into NCD care
Campaign led by the ESWI IDC, calling for better prevention, better care, better protection for people living with chronic diseases
(Recording available) IDC Partner Session at WOHC2026 - Exploring bidirectional links between respiratory viruses & non-communicable diseases
Now available to watch On Demand - IDC session at 9th World One Health Congress in Lisbon, 6 September 2026.
Maternal RSVpreF Vaccine Effectiveness Against Respiratory Syncytial Virus in Hospitalized Infants
maternal RSVpreF vaccination was associated with 78% to 81% reduction in RSV-associated hospitalization from birth through 6 months of age, with the highest vaccine effectiveness in earliest age intervals.
Commission signs joint procurement contract for up to 24 million doses of RSV vaccine ahead of the 2026-2027 winter season
The European Commission has signed a joint procurement framework contract with Moderna to access up to 24 million doses of the mRNA-based RSV (Respiratory Syncytial Virus) vaccine mRESVIA®.
Eight vaccines linked to a lower risk of dementia
A growing body of research is beginning to reveal the impact that regular routine vaccines could be having on the likelihood of conditions like dementia.
